Annual Current Assets
$745.13 M
+$235.14 M+46.11%
December 31, 2024
Summary
- As of March 12, 2025, PCRX annual total current assets is $745.13 million, with the most recent change of +$235.14 million (+46.11%) on December 31, 2024.
- During the last 3 years, PCRX annual current assets has fallen by -$120.92 million (-13.96%).
- PCRX annual current assets is now -13.96% below its all-time high of $866.05 million, reached on December 31, 2021.
Performance
PCRX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$745.13 M
+$55.16 M+7.99%
December 31, 2024
Summary
- As of March 12, 2025, PCRX quarterly total current assets is $745.13 million, with the most recent change of +$55.16 million (+7.99%) on December 31, 2024.
- Over the past year, PCRX quarterly current assets has stayed the same.
- PCRX quarterly current assets is now -13.96% below its all-time high of $866.05 million, reached on December 31, 2021.
Performance
PCRX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
PCRX Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +46.1% | 0.0% |
| 3 y3 years | -14.0% | +11.7% |
| 5 y5 years | +82.4% | +11.7% |
PCRX Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.0% | +49.5% | -14.0% | +98.1% |
| 5 y | 5-year | -14.0% | +82.4% | -14.0% | +98.1% |
| alltime | all time | -14.0% | +5837.8% | -14.0% | +5837.8% |
Pacira BioSciences Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $808.39 M(-24.1%) | $745.13 M(+8.0%) |
| Sep 2024 | - | $689.97 M(+9.1%) |
| Jun 2024 | - | $632.21 M(+16.4%) |
| Mar 2024 | - | $543.11 M(+6.5%) |
| Dec 2023 | $1.06 B(-10.0%) | $509.99 M(+14.0%) |
| Sep 2023 | - | $447.25 M(+4.2%) |
| Jun 2023 | - | $429.32 M(+14.1%) |
| Mar 2023 | - | $376.11 M(-24.5%) |
| Dec 2022 | $1.18 B(-2.2%) | $498.33 M(-6.6%) |
| Sep 2022 | - | $533.41 M(+1.4%) |
| Jun 2022 | - | $526.21 M(-21.1%) |
| Mar 2022 | - | $667.02 M(-23.0%) |
| Dec 2021 | $1.21 B(+94.1%) | $866.05 M(+5.3%) |
| Sep 2021 | - | $822.35 M(+3.8%) |
| Jun 2021 | - | $792.58 M(+10.0%) |
| Mar 2021 | - | $720.25 M(+10.5%) |
| Dec 2020 | $622.89 M(+47.4%) | $651.62 M(-1.0%) |
| Sep 2020 | - | $658.52 M(+44.5%) |
| Jun 2020 | - | $455.82 M(+5.6%) |
| Mar 2020 | - | $431.59 M(+5.6%) |
| Dec 2019 | $422.51 M(+99.9%) | $408.56 M(+7.8%) |
| Sep 2019 | - | $378.85 M(-4.0%) |
| Jun 2019 | - | $394.61 M(-22.4%) |
| Mar 2019 | - | $508.67 M(+6.4%) |
| Dec 2018 | $211.38 M(-10.9%) | $477.97 M(+1.3%) |
| Sep 2018 | - | $472.05 M(+3.7%) |
| Jun 2018 | - | $455.05 M(+8.7%) |
| Mar 2018 | - | $418.73 M(+7.1%) |
| Dec 2017 | $237.26 M | $391.11 M(+6.9%) |
| Sep 2017 | - | $365.83 M(-18.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $450.99 M(+0.7%) |
| Mar 2017 | - | $447.96 M(+84.3%) |
| Dec 2016 | $148.38 M(+9.8%) | $243.09 M(+3.2%) |
| Sep 2016 | - | $235.44 M(-8.7%) |
| Jun 2016 | - | $257.99 M(+3.8%) |
| Mar 2016 | - | $248.63 M(-1.6%) |
| Dec 2015 | $135.15 M(+20.9%) | $252.58 M(+8.4%) |
| Sep 2015 | - | $233.10 M(+1.5%) |
| Jun 2015 | - | $229.63 M(+4.5%) |
| Mar 2015 | - | $219.75 M(+2.6%) |
| Dec 2014 | $111.81 M(+77.3%) | $214.26 M(+7.5%) |
| Sep 2014 | - | $199.24 M(-4.6%) |
| Jun 2014 | - | $208.91 M(+112.1%) |
| Mar 2014 | - | $98.48 M(-7.7%) |
| Dec 2013 | $63.07 M(+23.3%) | $106.75 M(-4.4%) |
| Sep 2013 | - | $111.69 M(-8.1%) |
| Jun 2013 | - | $121.49 M(-5.8%) |
| Mar 2013 | - | $128.99 M(+111.7%) |
| Dec 2012 | $51.13 M(+65.8%) | $60.92 M(-28.4%) |
| Sep 2012 | - | $85.13 M(-14.9%) |
| Jun 2012 | - | $100.08 M(+60.7%) |
| Mar 2012 | - | $62.26 M(-24.7%) |
| Dec 2011 | $30.84 M(-13.1%) | $82.65 M(+90.4%) |
| Sep 2011 | - | $43.40 M(-19.0%) |
| Jun 2011 | - | $53.60 M(-16.3%) |
| Mar 2011 | - | $64.03 M(+106.2%) |
| Dec 2010 | $35.51 M(+13.1%) | $31.05 M(+52.3%) |
| Sep 2010 | - | $20.39 M(+7.7%) |
| Jun 2010 | - | $18.93 M(+50.9%) |
| Dec 2009 | $31.41 M(+0.7%) | $12.55 M |
| Dec 2008 | $31.18 M | - |
FAQ
- What is Pacira BioSciences annual total current assets?
- What is the all time high annual current assets for Pacira BioSciences?
- What is Pacira BioSciences annual current assets year-on-year change?
- What is Pacira BioSciences quarterly total current assets?
- What is the all time high quarterly current assets for Pacira BioSciences?
- What is Pacira BioSciences quarterly current assets year-on-year change?
What is Pacira BioSciences annual total current assets?
The current annual current assets of PCRX is $745.13 M
What is the all time high annual current assets for Pacira BioSciences?
Pacira BioSciences all-time high annual total current assets is $866.05 M
What is Pacira BioSciences annual current assets year-on-year change?
Over the past year, PCRX annual total current assets has changed by +$235.14 M (+46.11%)
What is Pacira BioSciences quarterly total current assets?
The current quarterly current assets of PCRX is $745.13 M
What is the all time high quarterly current assets for Pacira BioSciences?
Pacira BioSciences all-time high quarterly total current assets is $866.05 M
What is Pacira BioSciences quarterly current assets year-on-year change?
Over the past year, PCRX quarterly total current assets has changed by $0.00 (0.00%)